Archive: drug marketing
-
Drug Company Tricks: Patricia Bencivenga ’21 publishes Op-Ed in the Pittsburgh Post-Gazette
Patricia Bencivenga '21 recently published an Op-Ed in the Pittsburgh Post Gazette alongside Judy Butler on "Drug company tricks: Gaslighting the worried well into becoming the worried sick." Patrici
Category: News
-
Dangerous Fentanyl “Candy” Off the Market: Program Co-Director Adriane Fugh-Berman Published in The Kansas City Star
Last week, Program Co-Director Adriane Fugh-Berman published an opinion piece with PharmedOut colleague Judy Butler in The Kansas City Star. The piece covers the rise and fall of fentanyl lollipops,
Categories: News, News Story
-
Psychosis or Marketing Tactic? Daisy Daeschler ’21 Published in the International Journal of Social Determinants of Health and Health Services
Daisy Daeschler '21 has just published her research with Dr. Fugh-Berman on "Parkinson's Disease Psychosis and the Marketing of Pimavanserin." In the study, Daeschler and Fugh-Berman examine tren
Category: News
-
Deceptive Drug Samples: Student Emily Alagha Published in Journal of Pharmaceutical Policy and Practice
Emily Alagha, a HAPI student, published an article with Dr. Fugh-Berman in the Journal of Pharmaceutical Policy and Practice. The article, Pharmaceutical marketing: the example of drug samples, revie
Category: News
-
Pathologizing Ageing: Patricia Bencivenga ’21 publishes Op-Ed in the Baltimore Sun
Patricia Bencivenga '21 recently published an Op-Ed in the Baltimore Sun alongside Program Director Dr. Adriane Fugh-Berman on unnecessary prescribing for hot flashes...and just how dangerous these d
Category: News
-
What is Mild Cognitive Impairment? Patricia Bencivenga ’21 Publishes Op-Ed in the Baltimore Sun
Patricia Bencivenga '21 recently published an Op-Ed in the Baltimore Sun alongside Program Director Dr. Adriane Fugh-Berman on Alzheimer's and overprescribing of treatments. Patricia is currently wor
Category: News